Exploring the Promise of Flavonoids to Combat Neuropathic Pain: From Molecular Mechanisms to Therapeutic Implications
- PMID: 32587501
- PMCID: PMC7299068
- DOI: 10.3389/fnins.2020.00478
Exploring the Promise of Flavonoids to Combat Neuropathic Pain: From Molecular Mechanisms to Therapeutic Implications
Abstract
Neuropathic pain (NP) is the result of irregular processing in the central or peripheral nervous system, which is generally caused by neuronal injury. The management of NP represents a great challenge owing to its heterogeneous profile and the significant undesirable side effects of the frequently prescribed psychoactive agents, including benzodiazepines (BDZ). Currently, several established drugs including antidepressants, anticonvulsants, topical lidocaine, and opioids are used to treat NP, but they exert a wide range of adverse effects. To reduce the burden of adverse effects, we need to investigate alternative therapeutics for the management of NP. Flavonoids are the most common secondary metabolites of plants used in folkloric medicine as tranquilizers, and have been claimed to have a selective affinity to the BDZ binding site. Several studies in animal models have reported that flavonoids can reduce NP. In this paper, we emphasize the potentiality of flavonoids for the management of NP.
Keywords: GABA; benzodiazepines; flavonoids; neuronal injury; neuropathic pain.
Copyright © 2020 Uddin, Mamun, Rahman, Kabir, Alkahtani, Alanazi, Perveen, Ashraf, Bin-Jumah and Abdel-Daim.
Figures
Similar articles
-
Flavonoids as GABAA receptor ligands: the whole story?J Exp Pharmacol. 2012 Feb 23;4:9-24. doi: 10.2147/JEP.S23105. eCollection 2012. J Exp Pharmacol. 2012. PMID: 27186113 Free PMC article. Review.
-
Overview--flavonoids: a new family of benzodiazepine receptor ligands.Neurochem Res. 1997 Apr;22(4):419-25. doi: 10.1023/a:1027303609517. Neurochem Res. 1997. PMID: 9130252 Review.
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
Topical drug therapeutics for neuropathic pain.Expert Opin Pharmacother. 2018 Aug;19(11):1211-1220. doi: 10.1080/14656566.2018.1501026. Epub 2018 Jul 25. Expert Opin Pharmacother. 2018. PMID: 30044658 Review.
-
Mechanisms and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):71-8. doi: 10.2174/187152409787601932. Cent Nerv Syst Agents Med Chem. 2009. PMID: 20021340
Cited by
-
Attenuation of Streptozotocin-Induced Diabetic Neuropathic Allodynia by Flavone Derivative Through Modulation of GABA-ergic Mechanisms and Endogenous Biomarkers.Neurochem Res. 2024 Apr;49(4):980-997. doi: 10.1007/s11064-023-04078-5. Epub 2024 Jan 3. Neurochem Res. 2024. PMID: 38170385
-
The Multimodal Properties of Quercetin in Chronic Pain Syndromes.Indian J Palliat Care. 2023 Jul-Sep;29(3):334-335. doi: 10.25259/IJPC_151_2022. Epub 2023 Jul 11. Indian J Palliat Care. 2023. PMID: 37700889 Free PMC article. No abstract available.
-
Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents.Pharmaceutics. 2023 Apr 9;15(4):1193. doi: 10.3390/pharmaceutics15041193. Pharmaceutics. 2023. PMID: 37111679 Free PMC article. Review.
-
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics.JOR Spine. 2023 Jan 30;6(1):e1230. doi: 10.1002/jsp2.1230. eCollection 2023 Mar. JOR Spine. 2023. PMID: 36994457 Free PMC article. Review.
-
Luteolin: A promising natural agent in management of pain in chronic conditions.Front Pain Res (Lausanne). 2023 Mar 1;4:1114428. doi: 10.3389/fpain.2023.1114428. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 36937566 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
